The store will not work correctly when cookies are disabled.
4-methyl-6-(3-(methylamino)prop-1-yn-1-yl)pyridin-2-amine
ID: ALA5176637
Chembl Id: CHEMBL5176637
PubChem CID: 162463139
Max Phase: Preclinical
Molecular Formula: C10H13N3
Molecular Weight: 175.24
Associated Items:
Names and Identifiers
Canonical SMILES: CNCC#Cc1cc(C)cc(N)n1
Standard InChI: InChI=1S/C10H13N3/c1-8-6-9(4-3-5-12-2)13-10(11)7-8/h6-7,12H,5H2,1-2H3,(H2,11,13)
Standard InChI Key: NNABKXZKYMQGRR-UHFFFAOYSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 175.24 | Molecular Weight (Monoisotopic): 175.1109 | AlogP: 0.54 | #Rotatable Bonds: 1 |
Polar Surface Area: 50.94 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.46 | CX LogP: 1.45 | CX LogD: 0.36 |
Aromatic Rings: 1 | Heavy Atoms: 13 | QED Weighted: 0.61 | Np Likeness Score: -0.18 |
References
1. Vasu D, Li H, Hardy CD, Poulos TL, Silverman RB.. (2022) 2-Aminopyridines with a shortened amino sidechain as potent, selective, and highly permeable human neuronal nitric oxide synthase inhibitors., 69 [PMID:35772285] [10.1016/j.bmc.2022.116878] |